The Cetirizine Hydrochloride Injecti, cataloged under National Stock Number 6505-01-691-4547, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Tersera Therapeutics Llc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-691-4547 |
| Primary Part Number | NDC70720-0100-10 |
| Item Name | Cetirizine Hydrochloride Injecti |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Tersera Therapeutics Llc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC70720-0100-10 PRIMARY | Tersera Therapeutics Llc (USA) |
| Reference | Meaning |
|---|---|
| 1583588 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM206493 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-691-4547 is a Cetirizine Hydrochloride Injecti, manufactured by Tersera Therapeutics Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-691-4547 has 1 manufacturer part number on file: NDC70720-0100-10 (Tersera Therapeutics Llc).
Key specifications for NDC70720-0100-10: Special Features: INDICATED FOR THE TREATMENT OF ACUTE URTICARIA IN ADULTS AND CHILDREN 6 MONTHS OF AGE AND OLDER; SINGLE USE INJECTABLE PRODUCT FOR INTRAVENOUS ADMINISTRATION ONLY; CARTON CONTAINING 1 SINGLE-USE VIAL; SHOULD BE STORED AT 20 C TO 25 C (68 F TO 77 F), EXCURSIONS PERMITTED TO 15 - 30 C (59 - 86 F) (SEE USP CONTROLLED ROOM TEMPERATURE); DISCARD UNUSED PORTION; EACH 1 ML VIAL CONTAINS CETIRIZINE HYDROCHLORIDE 10 MG (EQUIVALENT TO 8.42 MG OF CETIRIZINE) AND SODIUM CHLORIDE FOR TONICITY ADJUSTMENT.; Part Name Assigned by Controlling Agency: CETIRIZINE HYDROCHLORIDE INJECTION, 10 MG/ML, VIAL. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.